Last edition
News about "CSIR-CDRI signs agreement with Marc Labs"
CSIR-CDRI signs agreement with Marc Labs to develop drug for heart attack and stroke
The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation. This may be helpful in treating patient population of coronary and cerebral artery diseases
CSIR-CDRI Signs Agreement With Marc Labs | 12/06/2021 | By Darshana | 326
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members